Statement on new EU choline chloride anti-dumping measures

On December 19, 2025, the European Union announced new anti-dumping duties on choline chloride imports from China, with tariffs ranging from 90.0% to 115.9%. This decision, welcomed by EU producers Eastman and Balchem, aims to protect the integrity of the EU food and feed supply chain from unfair trade practices. The enduring five-year measure, subject to renewal, underscores the EU's commitment to fair trade, safeguarding European jobs, and fostering industrial innovation.

EU manufacturers assert their capacity to meet the domestic demand for choline chloride, which is vital in numerous applications, particularly in food and animal nutrition. The anti-dumping duties are seen as essential for securing continued investment in local production facilities, thereby supporting economic stability and compliance with EU health and safety standards. Amidst global geopolitical uncertainties, reliance on imports subject to unfair pricing practices could jeopardize the European food supply.

The EU producers express gratitude towards the European Commission, particularly the Directorate-General for Trade (DG TRADE), for their dedication in establishing these trade barriers. Furthermore, the introduction of clarified customs origin rules will prevent circumvention of these duties, ensuring that choline chloride produced in China and subsequently processed in third countries retains its classification as Chinese product upon entry into the EU.

Overall, this regulatory move serves to bolster the EU's domestic choline chloride industry, reinforcing the importance of maintaining a stable, high-quality supply chain critical to both consumers and manufacturers alike. Balchem Corporation, which operates with segments dedicated to human and animal nutrition, remains poised to contribute significantly to this landscape moving forward.

The recent decision by the European Union to impose anti-dumping duties on choline chloride imports from China has significant implications for both producers like Eastman and Balchem and investors in the agriculture and specialty chemicals sectors. The duties, ranging from 90.0% to 115.9%, reflect the EU’s commitment to protecting domestic industries from unfair trade practices, which should bolster the competitive position of local producers.

From a market perspective, this move is likely to stabilize prices for choline chloride across the EU and enhance the profitability of domestic producers who can now operate in a less distorted market. Given that the EU producers have indicated sufficient capacity to meet current and projected demand, investment in local production and innovation may accelerate, presenting opportunities for growth. Investors should closely monitor how these anti-dumping measures affect market dynamics, particularly regarding supply stability and the overall health of EU agriculture.

Additionally, the clarity provided about customs origin rules will deter circumvention of these duties, thereby providing extra protection to local manufacturers. For companies involved in the supply chain—particularly those linked with animal and human nutrition divisions—there may be an uptick in demand as producers and retailers pivot to rely more heavily on domestically sourced choline chloride.

From a risk management perspective, investors should remain vigilant about geopolitical fluctuations that could impact supply chains further. While the EU is working to safeguard its market, any significant disturbances in global trade relationships could create unforeseen challenges.

Overall, stakeholders should consider engaging with companies within the EU choline chloride market, as this industry is poised to benefit in the short to medium term from these protective measures. Investing in firms with strong local production capabilities may yield favorable returns as they adapt to a changing regulatory landscape.